Tom Lee: The markets are in a buyer's strike, so buy the dip

Tom Lee: The markets are in a buyer's strike, so buy the dip

Tom Lee, Fundstrat Global Advisors head of research, joins the 'Halftime Report' to explain why he's advising investors to buy the dip despite market lows. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi 

Stocks tumbled on Tuesday, reversing Monday’s rebound on Wall Street, as investors reassessed risks associated with the new omicron Covid variant.

Major averages dropped to their session lows after Federal Reserve Chairman Jerome Powell said the central bank will discuss speeding up bond-buying taper at its December meeting.

The Dow Jones Industrial Average dropped about 605 points, dragged down by losses in American Express and Coca-Cola. The S&P 500 shed 1.6%. The technology-heavy Nasdaq Composite dipped 1.7%. The small-cap benchmark Russell 2000 dropped 2.4%.

In an appearance before a Senate committee, the Fed chief said he thinks reducing the pace of monthly bond buys can move quicker than the $15 billion a month schedule announced earlier this month.

“At this point, the economy is very strong and inflationary pressures are higher, and it is therefore appropriate in my view to consider wrapping up the taper of our asset purchases … perhaps a few months sooner,” Powell said. “I expect that we will discuss that at our upcoming meeting.”

Powell’s comments suggest that the Fed’s focus has now changed to fighting inflation and its negative impacts, rather than any more potential disruptions in economic activity from new variants of Covid.

Tuesday’s reversal also came after Moderna CEO Stephane Bancel told the Financial Times that he expects existing vaccines to be less effective against the new variant. The CEO told the paper there could be a “material drop” in the current vaccines’ effectiveness against this variant. Bancel told CNBC on Monday that it could take months to develop and ship an omicron-specific vaccine. Moderna was down nearly 7%.

Separately, Regeneron said its antibody treatment may have reduced effectiveness against omicron.

“The stock market is laser focused on news flow tied to Omicron,” said Jim Paulsen, chief investment strategist for Leuthold Group. On Monday “the rally was boosted by soothing reports from South Africa that its symptoms seemed to be mild, and this morning, it is being rocked by news from Moderna that Omicron could invalidate our existing vaccines and necessitate a new and improved vaccine which could take months to develop.”

Travel shares, which led Friday’s drop and then gained on Monday, were taking hits once again on Tuesday. Expedia Group fell 3.8%, Norwegian Cruise Line Holdings tumbled 5.4% and American Airlines shares were off by 4%.

“We have to expect...that the scenarios, all scenarios, include discoveries of people in this country with omicron and talk that the vaccines don’t work or if they did those who have had Covid have no immunity,” wrote CNBC’s Jim Cramer on Twitter Tuesday. “These all cause selling.”

The 10-year Treasury yield fell further below 1.45% as investors worried about the economy slowing because of the new variant. The 10-year rate lost 5 basis points to 1.47% (1 basis point equals 0.01%). The benchmark yield was as high as 1.69% last week before Friday’s drop below 1.5%.

Oil prices also declined on Tuesday with U.S. West Texas Intermediate (WTI) crude futures falling 5.4%, to trade at $66.16 per barrel.

Stocks’ move lower follows a volatile last few sessions as investors evaluate the omicron impact. The Dow lost 905 points on Friday, then rebounded by 237 points on Monday. Major averages rose to session highs on Monday after President Joe Biden said economic lockdowns are currently off the table and there will be no new travel restrictions.

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic 

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast 
 
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

https://www.cnbc.com/select/best-credit-cards/ 

#CNBC
#CNBCTV

Fast Money Halftime ReportCNBCbusiness news

Post a Comment

0 Comments